DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Mankind Pharma Limited — Notice Of Shareholders Meetings-XBRL

NSE 36 min ago·18 Aug 2026, 10:38 am

Mankind Pharma

Mankind Pharma has informed stock exchanges that it is convening a meeting to seek shareholder approval via postal ballot. This formal notice indicates the company is preparing to seek approval for specific corporate actions that require a vote from its investors.

For investors, this development is a routine procedural update. It signals that the company is moving forward with a specific agenda item, likely related to corporate governance or strategic decisions, which will be decided by the shareholders.

Investors should monitor the postal ballot results to understand the outcome of the specific proposal being voted upon. This information will clarify the company's upcoming plans and ensure transparency in the decision-making process.